Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity ; volume:18 ; number:1 ; day:15 ; month:9 ; year:2017 ; pages:1-11 ; date:12.2017
Respiratory research ; 18, Heft 1 (15.9.2017), 1-11, 12.2017
- Keyword
-
Atemwegskrankheit
Atemnot
- Creator
-
Sato, Seidai
- Contributor
-
Shinohara, Shintaro
Hayashi, Shinya
Morizumi, Shun
Abe, Shuichi
Okazaki, Hiroyasu
Chen, Yanjuan
Goto, Hisatsugu
Aono, Yoshinori
Ogawa, Hirohisa
Koyama, Kazuya
Nishimura, Haruka
Kawano, Hiroshi
Toyoda, Yuko
Uehara, Hisanori
Nishioka, Yasuhiko
SpringerLink (Online service)
- DOI
-
10.1186/s12931-017-0654-2
- URN
-
urn:nbn:de:1111-2017111710810
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sato, Seidai
- Shinohara, Shintaro
- Hayashi, Shinya
- Morizumi, Shun
- Abe, Shuichi
- Okazaki, Hiroyasu
- Chen, Yanjuan
- Goto, Hisatsugu
- Aono, Yoshinori
- Ogawa, Hirohisa
- Koyama, Kazuya
- Nishimura, Haruka
- Kawano, Hiroshi
- Toyoda, Yuko
- Uehara, Hisanori
- Nishioka, Yasuhiko
- SpringerLink (Online service)
Other Objects (12)
Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis
Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
Adhesive anti-fibrotic interfaces on diverse organs
Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
Anti-fibrotic effects of Nintedanib and Pirfenidone on alveolar epithelial cell function in ex-vivo 3D-Lung Tissue Cultures
Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis
Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
Adhesive anti-fibrotic interfaces on diverse organs
Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
Anti-fibrotic effects of Nintedanib and Pirfenidone on alveolar epithelial cell function in ex-vivo 3D-Lung Tissue Cultures
Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis
Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats
A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
Adhesive anti-fibrotic interfaces on diverse organs
Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis